- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Shruti Agnihotri Highlights the Importance of Value-Based Neurologic Care for Post–COVID-19 Patients
Shruti Agnihotri, MD, associate professor at the University of Alabama Birmingham, discusses how value-based care can help patients who experience neurologic chronic disease states after COVID-19, in addition to patients with conditions like stroke and dementia.
Value-based care is important for patients who experience neurologic issues after COVID-19, as well as patients with stroke and dementia, says Shruti Agnihotri, MD, associate professor at the University of Alabama Birmingham.
Transcript
What role does value-based care play in neurological conditions?
Value-based care is very important in neurologic conditions—many different neurologic conditions, of course, in things like dementia, strokes—but I think it's also important in our post–COVID-19 patient population. At the heart of what we do so far for our post–COVID-19 patients is managing high blood pressure, diabetes; the chronic conditions, chronic states, which affect how the brain will function for these patients. I think, yes, there is a large role that value-based care or managed care can play in these patient care situations.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
